Amneal Eu’s Generics Plerixafor Receives Approvals In US
Amneal`s Generic Methylprednisolone Receives Approval In US
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for the generic version of TobraDex®, which adds another complex ophthalmic product to the generics portfolio.
Amneal`s Generic Apremilast (10mg, 20mg and 30mg) Receives Approval in the U.S